1. Home
  2. CDT vs HAO Comparison

CDT vs HAO Comparison

Compare CDT & HAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDT
  • HAO
  • Stock Information
  • Founded
  • CDT 2019
  • HAO 2018
  • Country
  • CDT United States
  • HAO China
  • Employees
  • CDT N/A
  • HAO N/A
  • Industry
  • CDT Biotechnology: Pharmaceutical Preparations
  • HAO
  • Sector
  • CDT Health Care
  • HAO
  • Exchange
  • CDT Nasdaq
  • HAO NYSE
  • Market Cap
  • CDT 5.2M
  • HAO 4.2M
  • IPO Year
  • CDT N/A
  • HAO 2024
  • Fundamental
  • Price
  • CDT $1.93
  • HAO $1.39
  • Analyst Decision
  • CDT
  • HAO
  • Analyst Count
  • CDT 0
  • HAO 0
  • Target Price
  • CDT N/A
  • HAO N/A
  • AVG Volume (30 Days)
  • CDT 290.9K
  • HAO 25.8K
  • Earning Date
  • CDT 08-11-2025
  • HAO 08-08-2025
  • Dividend Yield
  • CDT N/A
  • HAO N/A
  • EPS Growth
  • CDT N/A
  • HAO N/A
  • EPS
  • CDT N/A
  • HAO 0.19
  • Revenue
  • CDT N/A
  • HAO $48,970,924.00
  • Revenue This Year
  • CDT N/A
  • HAO N/A
  • Revenue Next Year
  • CDT N/A
  • HAO N/A
  • P/E Ratio
  • CDT N/A
  • HAO $6.96
  • Revenue Growth
  • CDT N/A
  • HAO 15.04
  • 52 Week Low
  • CDT $1.90
  • HAO $0.84
  • 52 Week High
  • CDT $622.50
  • HAO $124.25
  • Technical
  • Relative Strength Index (RSI)
  • CDT 28.61
  • HAO 51.92
  • Support Level
  • CDT $1.94
  • HAO $1.26
  • Resistance Level
  • CDT $2.31
  • HAO $1.45
  • Average True Range (ATR)
  • CDT 0.16
  • HAO 0.08
  • MACD
  • CDT 0.04
  • HAO -0.00
  • Stochastic Oscillator
  • CDT 7.02
  • HAO 59.05

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

About HAO HAOXI HEALTH TECHNOLOGY LTD

Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. Haoxi has been rooted in the field of local online effect marketing for many years, serving customers in various industries at home and abroad, and its main business is the medical industry. It generates its revenue by providing one-stop online marketing solutions, in particular online short video marketing solutions, to advertisers through its media partners. The company provides customized marketing solutions by planning, producing, placing, and optimizing online ads, especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms.

Share on Social Networks: